Viewing Study NCT04777851


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-01 @ 1:39 AM
Study NCT ID: NCT04777851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-15
First Post: 2021-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
Sponsor: Translational Research in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module